This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
5 Inverse ETFs That Gained More Than 20% in April
by Sweta Killa
The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market's worst month of 2024. This has resulted in huge gains for inverse or inverse-leveraged ETFs.
5 Best Inverse-Leveraged ETFs of Last Week
by Sanghamitra Saha
Last week witnessed the largest collective loss for the "Magnificent Seven" technology-related stocks, with a total of $950 billion erased from their market capitalizations.
Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street delivered a downbeat performance last week.
Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street delivered a decent performance last week.
5 Inverse ETFs That Gained More Than 25% in October
by Sweta Killa
The U.S. stock market wrapped up October with losses, marking the third-straight monthly decline for the first time since the onset of the COVID pandemic in March 2020.
Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street delivered a downbeat performance last week.
Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street gave a mixed performance last week with the S&P 500 and the Nasdaq Composite eking out moderate gains while the Dow Jones and the Russell 2000 slumped.
The Zacks Analyst Blog Highlights AdvisorShares MSOS 2x Daily ETF, MicroSectors U.S. Big Oil Index 3X Leveraged ETN, Direxion Daily 20+ Year Treasury Bear 3x Shares, MAX Airlines -3X Inverse Leveraged ETN and Direxion Daily S&P Biotech Bear 3x Shares
by Zacks Equity Research
AdvisorShares MSOS 2x Daily ETF, MicroSectors U.S. Big Oil Index 3X Leveraged ETN, Direxion Daily 20+ Year Treasury Bear 3x Shares, MAX Airlines -3X Inverse Leveraged ETN and Direxion Daily S&P Biotech Bear 3x Shares are included in this Analyst Blog.
5 Leveraged/Inverse ETFs That Gained More Than 40% in Q3
by Sweta Killa
The third quarter proved to be highly volatile and uncertain for the U.S. stock market.
5 Best Leveraged-Inverse ETFs of September
by Sweta Killa
September is on track to be the worst month of the year.
Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street delivered a downbeat show last week with the S&P 500 and Nasdaq logging worst weeks since March due to rising rate worries.
5 Inverse ETFs That Gained in Double Digits in August
by Sweta Killa
August was dull for Wall Street, with all three major indices finishing in the red. This resulted in huge demand for inverse or inverse-leveraged ETFs as these fetch outsized returns on bearish sentiments in a short span.
Inverse ETFs Soar as Market Turns Sour
by Sweta Killa
Wall Street has been caught in feeble trading in the past week, triggered by the U.S. credit rating downgrade and now bank downgrades. This has resulted in huge demand for inverse or inverse-leveraged ETFs.
5 Factors Why Inverse ETFs May Rule in 2H23
by Sanghamitra Saha
As short-sellers increase their bets against U.S. equities amidst a booming S&P 500 Index, we delve into why inverse ETFs may come to dominate the latter half of 2023.
5 Best Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street was upbeat last week. Abating banking crisis and a less-hawkish Fed led to the rally in Wall Street.
ETF Winners From the Fed Meeting & Yellen's Testimony
by Sanghamitra Saha
Inverse ETFs surged yesterday despite the Fed's less-hawkish tone. Yellen's testimony probably have triggered the market selloffs.
5 Best Inverse-Leveraged ETFs of February
by Sweta Killa
Wall Street gave a dismal performance last month on Fed's longer-than-expected rate hike speculation, with all three major indices in red.
5 Least-Hurt Biotech ETFs of the Last Week
by Sanghamitra Saha
Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.
Best Inverse/Leveraged ETF Areas of Last Week
by Sanghamitra Saha
Wall Street was downbeat last week. The S&P 500 and the Nasdaq recorded the worst week since December.
Best Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street was downbeat last week, probably due to the relentless market forecasts of a looming recession and an uncertain Fed rate outlook.
5 Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street was downbeat last week. Each of the key equity gadgets -- the S&P 500 (down 0.7%), the Dow Jones (down 0.01.%), the Nasdaq Composite (down 1.6%) and the Russell 2000 (down 1.8%) -- lost last week.
Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street was downbeat last week. Rising rate worries and recessionary fears were the key concerns.
Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street was downbeat last week on rising rate worries and FedEx'
Best Inverse/Leveraged ETFs of Last Week
by Sanghamitra Saha
Wall Street was moderately downbeat last week due to a rise in bond yields.
Inverse or Leveraged ETFs That More Than Doubled This Year
by Sweta Killa
The year 2022 has been brutal so far for the stock market, with the S&P 500 Index plunging in bear-market territory.